Smith, A. B.; Beauchamp, T. J.; LaMarche, M. J.; Kaufman, M. D.; Qiu, Y.; Arimoto, H.; Jones, D. R.; Kobayashi, K. J. Am. Chem. Soc.2000, 122, 8654-8664. (Article)
Mickel, S. J. et al.Org. Process Res. Dev.2004, 8, 92, 101, 107, 113 and 122.
Klein, L. E.; Freeze, B. S.; Smith, A. B.; Horwitz, S. B. Cell Cycle2005, 4, 501-507. (Article)
nih.gov
ncbi.nlm.nih.gov
Ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M., Longley, R. E.; Gunasekera, S. P.; Rosenkranz, H. S.; Day, B. W. Biochemistry1996, 35, 243-250. (Abstract)
Hung, D. T.; Chen, J.; Schreiber, S. L. Chem Biol.1996, 3, 287-293. (Abstract)
A phase I pharmacokinetic (PK) trial of XAA296A (Discodermolide) administered every 3 wks to adult patients with advanced solid malignancies. 2004 ASCO Annual Meeting (Abstract and Presentation Slides)